NEWARK, DE, March 22, 2017 — LiteCure, LLC is pleased to welcome Col. Dallas C. Hack, MD and Jackson Streeter, MD to their medical advisory board. The extensive knowledge brought by these esteemed members of the scientific community will be beneficial as LiteCure continues to lead in the development and therapeutic application of photobiomodulation-based technologies.
A key figure at several innovative companies, Dr. Streeter offers years of experience driving advancements in medical technology. He is the inventor on over twenty patents and author on multiple scientific publications. His extensive industry experience will provide the board with valuable insight into the ever-changing medical marketplace. To read Dr. Streeter’s full biography, please click here.
Col. Hack is a highly distinguished medical professional who has made significant contributions toward advancing traumatic brain injury (TBI) research and technology. He has managed over 650 TBI related projects and played a large role in establishing the largest concussion study to date. Col. Hack’s extensive therapeutic experience will greatly expand the board’s current breadth of medical knowledge. To read Col. Hack’s full biography, please click here.
About LiteCure, LLC
Located in Newark, DE, LiteCure is a registered manufacturer providing FDA cleared products for a variety of medical and veterinary applications. LiteCure is the parent of the LightForce Therapy Laser and Companion Animal Health divisions. Each product has been designed and manufactured under stringent quality control systems that are certified to meet ISO-13485 standards for medical devices. LiteCure is committed to providing the highest performance and quality products to health care professionals. Constant product innovation and industry-leading customer service allow LiteCure to provide the most comprehensive therapy and implementation solutions in the market.
